NovoCure (NVCR) Change in Acquisitions & Divestments (2014 - 2026)

NovoCure has disclosed Change in Acquisitions & Divestments across 13 years of filings, most recently posting $110.0 million for Q1 2026.

• Change in Acquisitions & Divestments for Q1 2026 came in at $110.0 million, down 8.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 billion (up 99.22% YoY), and the FY2025 annual result was $1.3 billion, up 65.17% from the prior year.
• Change in Acquisitions & Divestments came in at $110.0 million for Q1 2026 at NovoCure, down from $560.0 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $560.0 million in Q4 2025 to a low of $104.5 million in Q4 2022.
• The 5-year median for Change in Acquisitions & Divestments is $275.5 million (2023), against an average of $268.7 million.
• Across the five-year window, Change in Acquisitions & Divestments tumbled 54.11% in 2022 and soared 229.41% in 2025, its largest moves.
• NovoCure's Change in Acquisitions & Divestments stood at $104.5 million in 2022, then soared by 185.62% to $298.5 million in 2023, then tumbled by 43.06% to $170.0 million in 2024, then jumped by 229.41% to $560.0 million in 2025, then plunged by 80.36% to $110.0 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $110.0 million (Q1 2026), $560.0 million (Q4 2025), and $185.0 million (Q3 2025), per Business Quant data.